Mi SciELO
Servicios Personalizados
Revista
Articulo
Indicadores
- Citado por SciELO
- Accesos
Links relacionados
- Citado por Google
- Similares en SciELO
- Similares en Google
Compartir
Sanidad Militar
versión impresa ISSN 1887-8571
Resumen
SANCHEZ LOPEZ, P; PRATS OLIVAN, P; APARICIO HERNANDEZ, R y GARCIA LUQUE, A. Positive assessment of drugs: December 2018, January and February 2019. Sanid. Mil. [online]. 2019, vol.75, n.2, pp.94-97. ISSN 1887-8571. https://dx.doi.org/10.4321/s1887-85712019000100006.
The drugs assessed by the Spanish Agency for Medicines and Health Products or European Medicines Agency made public in December 2018, January and February of 2019 , and considered of interest to the healthcare professional, are reviewed. These are positive technical reports prior to the authorization and placing on the market of the product.
Palabras clave : Andexanet Alfa (Ondexxya®); Dacomitinib (Vizimpro®); Fremanezumab (Ajovy®); Lorlatinib (Lorviqua®); Lusutrombopag (Lusutrombopag Shionogi®); Naldemedina (Rizmoic®); Pegvaliase (Palynziq®); Risankizumab (Skyrizi®); Ropeginterferon alfa 2-B (Besremi®); Sotagliflozin (Zynquista®); Treosulfan (Trecondi®); Volanesorsen (Waylivra®); Zanamivir (Dectova®).